Deciphering splenic marginal zone lymphoma pathogenesis: The proposed role of microRNA

Jacob E. Robinson, Christine E. Cutucache

Research output: Contribution to journalReview article

Abstract

Splenic marginal zone lymphoma (SMZL) is a malignancy of mature B-cells that primarily involves the spleen, but can affect peripheral organs as well. Even though SMZL is overall considered an indolent malignancy, the majority of cases will eventually progress to be more aggressive. In recent years, the gene expression profile of SMZL has been characterized in an effort to identify: 1) the etiology of SMZL, 2) biological consequences of SMZL, and 3) putative therapeutic targets. However, due to the vast heterogeneity of the malignancy, no conclusive target(s) have been deciphered. However, the role of miRNA in SMZL, much as it has in chronic lymphocytic leukemia, may serve as a guiding light. As a result, we review the comprehensive expression profiling in SMZL to-date, as well as describe the miRNA (and potential mechanistic roles) that may play a role in SMZL transformation, particularly within the 7q region.

Original languageEnglish (US)
Pages (from-to)30005-30022
Number of pages18
JournalOncotarget
Volume9
Issue number52
DOIs
Publication statusPublished - Jul 1 2018

    Fingerprint

Keywords

  • 7q
  • CAV1
  • Caveolin-1
  • MicroRNA
  • Splenic marginal zone lymphoma

ASJC Scopus subject areas

  • Oncology

Cite this